INTEX PHARMA – ANDARINE S-4 25mg / 60 tabs
$45.00 Original price was: $45.00.$38.96Current price is: $38.96.
Muscle Hypertrophy: S-4 (Andarine) is thought to promote muscle hypertrophy, leading to an increase in muscle size and strength. By selectively binding to androgen receptors in muscle tissues, it may stimulate protein synthesis, which is crucial for muscle repair and growth.
Enhanced Strength: Users of S-4 often report improvements in strength levels, allowing them to engage in more demanding workouts and resistance training. This enhanced strength can lead to more effective muscle-building exercises.
Body Composition: While primarily sought after for its muscle-enhancing benefits, S-4 (Andarine) is believed to contribute to a more favorable body composition. Some users claim it may support a reduction in body fat, leading to a leaner and more defined physique when combined with appropriate nutrition and exercise.
Potential Joint Support: The anabolic effects of S-4 on muscle tissue may also offer secondary benefits for joint support. Strengthened muscles surrounding joints can provide better stability and potentially reduce the risk of joint-related injuries during physical activities.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Reviews
There are no reviews yet.